News
Respiratory syncytial virus is common but it can be dangerous for some infants and young kids. Here's everything parents need ...
A major UK-led clinical trial has found that a treatment commonly used to help premature babies breathe offers no benefit for ...
Understanding the differences between colds, flu, and RSV can help in identifying the illness you're dealing with, the ...
The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...
Enjoy, and see you soon… A fast-growing group of Americans is turning to what many call the “gray market” for obesity ...
The CDC's Advisory Committee on Immunization Practices (ACIP) has issued new vaccine recommendations affecting RSV and flu ...
Enflonsia is an extended half-life RSV fusion glycoprotein neutralizing monoclonal antibody that is designed to provide durable protection through 5 months.
A medical panel appointed by Health Secretary Robert F. Kennedy Jr. voted Thursday to recommend a new antibody treatment ...
A new national guideline provides evidence-based recommendations for diagnosing, treating, and preventing pediatric ...
A virus that once filled pediatric hospital beds and terrified new parents is finally being pushed back—before babies are ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results